23510-92-1

Basic information

• Product Name: 4β-Ethoxycyclohexanone
• Synonyms: 4-Ethoxycyclohexanone;4β-Ethoxycyclohexanone;1-Ethoxy-4-oxocyclohexane;4-Ethoxycyclohexan-1-one 97%;4-Ethoxycyclohexan-1-one97%;4-ethoxycyclohexan-1-one
• CAS NO: 23510-92-1
• Molecular Formula: C₈H₁₄O₂
• Molecular Weight: 142.2
• Mol File: 23510-92-1.mol

Chemical Properties

• Boiling Point: 88-90 °C(Press: 12 Torr)
• Appearance: /
• Density: 0.97±0.1 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 4β-Ethoxycyclohexanone(CAS DataBase Reference)
• NIST Chemistry Reference: 4β-Ethoxycyclohexanone(23510-92-1)
• EPA Substance Registry System: 4β-Ethoxycyclohexanone(23510-92-1)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 23510-92-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical and Agrochemical Industries:
4β-Ethoxycyclohexanone serves as a crucial building block in the synthesis of various organic compounds, particularly in the development of pharmaceuticals and agrochemicals. Its unique structure allows for the creation of a wide range of molecules with potential therapeutic and agricultural applications.
Used as a Flavoring Agent in the Food Industry:
Leveraging its sweet, fruity scent, 4β-Ethoxycyclohexanone is utilized as a flavoring agent in the food industry. It enhances the taste and aroma of various food products, contributing to a more enjoyable consumer experience.
Used as a Fragrance in the Cosmetic Industry:
In addition to its applications in the food sector, 4β-Ethoxycyclohexanone is also employed as a fragrance in the cosmetic industry. Its pleasant odor makes it suitable for incorporation into perfumes, lotions, and other personal care products, adding a desirable scent and improving the overall appeal of these cosmetics.

Upstream product

• 556-48-9 1,4-Cyclohexanediol 
• 622-62-8 4-Ethoxyphenol 
• 637-88-7 1,4-Cyclohexanedione 
• 22428-87-1 4,4-ethylenedioxycyclohexan-1-ol 
• 4746-97-8 cyclohexanedione monoethylene ketal 
• 55103-52-1 4-ethoxycyclohexanone ethylene ketal 
• 75-03-6 ethyl iodide 
• 106349-63-7 4-ethoxycyclohexan-1-ol 

Downstream Products

• 35427-92-0 Aethyl-4-methyl-3-cyclohexenyl-aether 
• 192504-15-7 4-Ethoxycyclohexanon-2,2,6,6-d⁽⁴⁾ 
• 106349-63-7 4-ethoxycyclohexan-1-ol 
• 192504-16-8 C₈H₁₅⁽²⁾HO₂ 
• 106421-17-4 ethyl-cyclohex-3-enyl ether 
• 1134196-92-1 3-{1-[trans-4-(ethyloxy)cyclohexyl]-4-piperidinyl}-5-fluoro-1,3-benzoxazol-2(3H)-one 
• 1315073-06-3 4-2-[2-(2-methoxyethoxy)ethoxy]ethoxycyclohexanone 
• 90722-88-6 4-Ethoxy-1-trichlormethyl-cyclohexanol-⁽¹⁾ 

Relevant articles and documents

IRAK INHIBITORS AND METHOD FOR MAKING AND USING

Disclosed embodiments concern interleukin receptor associated kinases (IRAK) inhibitors, such as oxazole compounds, and compositions comprising such inhibitors. Also disclosed are methods of making and using the compounds and compositions. The disclosed c

AMIDE COMPOUNDS AND METHOD FOR MAKING AND USING

Disclosed embodiments concern novel interleukin receptor associated kinases (IRAK) inhibitors and compositions comprising such inhibitors. Also disclosed are methods of making and using the compounds and compositions. The disclosed compounds and/or compos

Thermoresponsive star-like γ-substituted poly(caprolactone)s for micellar drug delivery

Temperature responsive drug carriers are attractive due to their ability to provide controlled release of the encapsulated cargo based on the use of external stimuli. In this work, 4- and 6-arm thermoresponsive star-like block copolymers were synthesized

PIPERAZINE DERIVATIVES AS HIV PROTEASE INHIBITORS

The present invention is directed to compounds of Formula I pharmaceutical compositions comprising the same, and their use in the inhibition of HIV protease, the inhibition of HIV replication, the prophylaxis of infection by HIV, the treatment of infection by HIV, and the prophylaxis, treatment, and delay in the onset or progression of AIDS.

A combined experimental and computational study of the substituent effect on micellar behavior of γ-substituted thermoresponsive amphiphilic poly(ε-caprolactone)s

The effect of the core substituent structure on the micellar behavior of thermoresponsive amphiphilic poly(ε-caprolactone) diblock copolymer micelles was investigated through a combination of experimental and computational methods. The polycaprolactone (P

CYCLOHEXYL-AZETIDINYL ANTAGONISTS OF CCR2

The present invention comprises compounds of Formula (I). wherein: R1, R2, X, and Z are as defined in the specification. The invention also comprises a method of preventing, treating or ameliorating a syndrome, disorder or disease, wherein said syndrome, disorder or disease is type II diabetes, obesity and asthma. The invention also comprises a method of inhibiting CCR2 activity in a mammal by administration of a therapeutically effective amount of at least one compound of Formula (I).

1- (1-CYCLOHEXYL-4-PIPERIDINYL) -1, 3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE DERIVATIVES WHICH HAVE ACTIVITY ON THE M1 RECEPTOR AND THEIR USE IN MEDICINE

Compounds of formula (I) or a salt thereof are provided, wherein X1, X2, X3, R6, Q and R are as defined in the description. Uses of the compounds as medicaments and in the manufacture of medicaments for treating

BENZIMIDAZOLES WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE

Compounds of Formula (I) and salts and solvates are provided; wherein R, R5, R6 and Q are defined as in the claims. Uses of the compounds for therapy, for example in the treatment of psychotic disorders and cognitive impairment, are also disclosed.

BENZIMIDAZOLES WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE

Compounds of formula (I), salts and solvates are provided: formula (I), wherein Q, R and R6 are as defined in the claims. Uses of the compounds for therapy, for example in the treatment of psychotic disorders and cognitive impairment, are also disclosed.

New bioorganic reagents: Evolved cyclohexanone monooxygenase - Why is it more selective?

Four mutants of the cyclohexanone monooxygenase (CHMO) evolved as catalysts for Baeyer-Villiger oxidation of 4-hydroxycyclohexanone were investigated as catalysts for a variety of 4-substituted and 4,4-disubstituted cyclohexanones. Several excellent catalytic matches (mutant/substrate) were identified. The most important, however, is the finding that, in a number of cases, a mutant with a single exchange, Phe432Ser, was shown to be as robust and more selective as a catalyst than the wild-type CHMO. All biotransformations were performed on a laboratory scale, allowing full characterization of the products. The absolute configurations of two products were established. A model suggesting a possible role of the 432 serine residue in enantioselectivity control is proposed.